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Mycobacterium tuberculosis is the species of bacteria that
is the causative agent of tuberculosis. Those at high risk
for tuberculosis include the elderly, infants, and individuals
already infected with a disease that affects the immune
system. This makes M. tuberculosis a common source
of nosocomial infections, and the emergence of drugresistant strains of the bacteria calls for research into new
drugs for treatment of infection with M. tuberculosis. One
possible method of treatment involves targeting a putative
exopolyphosphatase encoded by the gene Mt1054. An
Escherichia coli homologue of this protein regulates the
levels of polyphosphate and guanosine 5’-triphosphate
3’-diphosphate (pppGpp), both of which act as signaling
molecules during amino acid starvation. The presence of
the protein encoded by Mt1054 has been shown to affect
biofilm formation and sliding motility in Mycobacterium

smegmatis. In this research, Mt1054 will be inserted into the
expression plasmid pET30. The protein will be expressed
and purified, and enzymatic assays will be conducted on the
purified protein in order to determine its phosphohydrolytic
enzyme activity. This information can be used in the
future to develop methods of modulating M. tuberculosis
exopolyphosphatase activity. By doing so, clinicians may
be able to trick the bacteria out of going into stationary
phase and developing biofilms. Disrupting the ability
of M. tuberculosis to form biofilms could increase the
susceptibility of this bacterium to antibiotics and decrease
the mortality rate of this potentially deadly disease.
Research advisor David A. Sanders writes, “There will
be 9,000,000 new cases and 1,400,000 deaths from
tuberculosis this year. Brandt Lydon is investigating the
function of a protein that makes the decision between
rapid and slow growth of the bacterium Mycobacterium
tuberculosis that causes tuberculosis. His independent
research may contribute to increasing the susceptibility
of the bacterium to antibiotics.”
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